LLY

902.74

-0.9%↓

UNH

596.8

+0.31%↑

NVO

131.05

+0.18%↑

JNJ

164.37

-0.29%↓

ABBV

193.18

+0.34%↑

LLY

902.74

-0.9%↓

UNH

596.8

+0.31%↑

NVO

131.05

+0.18%↑

JNJ

164.37

-0.29%↓

ABBV

193.18

+0.34%↑

LLY

902.74

-0.9%↓

UNH

596.8

+0.31%↑

NVO

131.05

+0.18%↑

JNJ

164.37

-0.29%↓

ABBV

193.18

+0.34%↑

LLY

902.74

-0.9%↓

UNH

596.8

+0.31%↑

NVO

131.05

+0.18%↑

JNJ

164.37

-0.29%↓

ABBV

193.18

+0.34%↑

LLY

902.74

-0.9%↓

UNH

596.8

+0.31%↑

NVO

131.05

+0.18%↑

JNJ

164.37

-0.29%↓

ABBV

193.18

+0.34%↑

Search

McKesson Corp

Closed

Sector Healthcare

504.35 -2.22

Overview

Share price change

24h

Current

Min

504.3

Max

507.9

Key metrics

By Trading Economics

Income

124M

915M

Sales

2.9B

79B

P/E

Sector Avg

26.08

103.001

EPS

7.88

Profit margin

1.154

EBITDA

-82M

1.3B

Recommendations

By TipRanks

Recommendations

Strong Buy

12 Months Forecast

+24.24 upside

Dividends

By Dow Jones

Next Earnings

30 Oct 2024

Next Dividend date

1 Oct 2024

Next Ex Dividend date

28 Nov 2024

Market Stats

By TradingEconomics

Market Cap

552M

74B

Previous open

506.57

Previous close

504.35

News Sentiment

By Acuity

52%

48%

313 / 365 Healthcare

Technical Score

By Trading Central

Confidence

Very Strong Bearish Evidence

McKesson Corp Chart

Related News

8 Aug 2024, 14:41 UTC

Top News

Dow Gains 450 Points As Jobs Data Surprises; Warner Bros. Discovery Among Sell Signals (Live Coverage) -- IBD

8 Aug 2024, 08:43 UTC

Top News

Dow Jones Futures Fall After Nvidia-Led Market Reversal; Five Earnings Movers -- IBD

3 Nov 2023, 14:39 UTC

Earnings

Cardinal Health, Cencora Break Out With Assist From GLP-1 Demand -- IBD

Peer Comparison

Price change

McKesson Corp Forecast

Price Target

By TipRanks

24.24% upside

12 Months Forecast

Average 626.36 USD  24.24%

High 670 USD

Low 503 USD

Based on 13 Wall Street analysts offering 12 month price targets forMcKesson Corp - Dist in the last 3 months.

Rating Consensus

By TipRanks

Strong Buy

13 ratings

11

Buy

2

Hold

0

Sell

Technical Score

By Trading Central

N/A / 555Support & Resistance

Short Term

Very Strong Bearish Evidence

Intermediate Term

Very Strong Bearish Evidence

Long Term

Bearish Evidence

Sentiment

By Acuity

313 / 365 Healthcare

News Sentiment

Bearish Evidence

Volatility

Below average

News Volume (RCV)

Below average

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About McKesson Corp

McKesson Corporation is focused distributing pharmaceuticals and providing health information technology, medical supplies, and care management tools. The Company’s segments include U.S. Pharmaceutical, International, Medical-Surgical Solutions, and Prescription Technology Solutions (RxTS). The U.S. Pharmaceutical segment provides distribution and logistics services for branded, generic, specialty, biosimilar, and over-the-counter pharmaceutical drugs and other healthcare-related products. The International segment provides distribution and services to wholesale, institutional, and retail customers in 13 European countries and Canada. Medical-Surgical Solutions segment provides medical-surgical supply distribution, logistics, and other services to healthcare providers. RxTS segment combines its technologies, including CoverMyMeds, RelayHealth, RxCrossroads, and McKesson Prescription Automation, to serve its biopharma and life sciences partners and patients.